The new mushroom changing cancer care across North America: Black Maitake

Shogun Maitake and the University of Windsor Bring New Hope to Cancer Care in North America

In Canada, 2 in 5 people will be diagnosed with cancer in their lifetime. Although this is a grave statistic, one Ontario company, Shogun Maitake, is instilling new hope and changing cancer care in North America in collaboration with the University of Windsor.

A Revolutionary Ingredient: Odaira Black Maitake Extract (OBME)

Shogun Maitake, a producer of high-quality and Health Canada-approved black maitake mushrooms, has spent years innovating the revolutionary ingredient at the heart of this research: Odaira Black Maitake Extract (OBME). Led by Dr. Siyaram Pandey and research students at the University of Windsor, the clinical studies conducted on OBME reveal incredible findings that are reshaping how cancer is treated.

The findings demonstrate the anti-cancer effects of OBME and how it successfully induces cancer cell death, boosts the immune system, reduces tumour growth, enhances the efficacy of current chemotherapeutics when used in combination, and decreases treatment toxicity in patients, thereby contributing to an improved quality of life.

Student Research and Breakthrough Discoveries

One of the lead research students under Dr. Pandey, at the University of Windsor, Hannah Drew, MSc, said, “In my 2 years of working with the Shogun Maitake OBME, we’ve tested it against multiple forms of cancer, including breast, colorectal, and prostate and saw that it successfully destroyed cancerous cells while maintaining the integrity of healthy ones.”

Another lead research student, Sona Regonda, MSc, noted that “Since there are no side effects in using naturopathic treatments in conjunction with traditional chemotherapeutics, it provides a cost-effective avenue to cancer care, especially for those with a lower socioeconomic status and actually improves quality of life.”

Expert Insights on Immunomodulation

This remained the consensus as we spoke to Dr. Ehab Mohammed (ND) to understand how a naturopathic remedy can have such incredible effects. He explained that “Supporting the immune system, first and foremost, changes the patient’s position from very vulnerable to able, allowing the body to combat the side effects of chemotherapy.”

OBME is an immunomodulator, meaning it works by modifying the body’s immune response to enhance its ability to fight disease. These immune-supporting properties are inherent to Black Maitake extract, but Shogun Maitake’s supplements represent the most potent version available on the market.

A Patient Story: Tania Atkin’s Remarkable Recovery

An example of the healing powers of OBME in action can be seen in the extraordinary story of Tania Atkin, a patient of Dr. Mohammed, who was diagnosed with Multiple Myeloma and utilized Shogun Maitake’s combination care of Prothera and EX, two products that boost the optimal and potent dosage of OBME.

“When I was put on Prothera during chemotherapy, the doctors were shocked that I was fine. I was working out, training, and living normally, without the traditional chemotherapy side effects,” said Tania. Throughout her treatment, Tania’s immune system stayed intact, allowing her body to fight the cancer.

“I’ve been in remission for 3 years, but I’m not waiting for it to come back. I will continue taking Prothera to ensure there are no recurrences, and because of its immunomodulating properties, I’ve never become immunocompromised,” she explained.

The Future of OBME in Cancer Care

Shogun Maitake’s OBME represents new hope for cancer care in North America, offering a natural option for cancer patients in the region. With successful results in Phase 1 and 2 of clinical trials, the next phase of the project will further assess the effectiveness of OBME in combination with immunotherapy, with the aim of supporting even more patients on their cancer journeys.

To learn more about Shogun Maitake and to shop the products, visit shogunmaitake.com.